Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Murgia, Nicola ^a,b   Brisman, Jonas ^a   Claesson, Annika ^a   Muzi, Giacomo ^b   Olin, Anna Carin ^a   Torén, Kjell ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Accuracy; Airway obstruction; ATS ERS; GOLD; Sensitivity; Spirometry

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; AMERICAN THORACIC SOCIETY/EUROPEAN RESPIRATORY SOCIETY CRITERIA; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION; PREDICTIVE VALUE; QUESTIONNAIRE; SELF REPORT; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SWEDEN;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84899130008     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-49     Document Type: Article

References (35)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370(9589):765-773. 10.1016/S0140-6736(07)61380-4, 17765526.
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-555. 10.1164/rccm.200703-456SO, 17507545, Global Initiative for Chronic Obstructive Lung Disease.
3. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P, American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American college of physicians, American college of chest physicians, American thoracic society, and European respiratory society. Ann Intern Med 2011, 155(3):179-191. 10.7326/0003-4819-155-3-201108020-00008, 21810710, American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society.
4. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS, GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: national heart, lung, and blood institute and world health organization global initiative for chronic obstructive lung disease (GOLD): executive summary. Respir Care 2001, 46(8):798-825. GOLD Scientific Committee.
5. Townsend MC. Conflicting definitions of airways obstruction drawing the line between normal and abnormal. Chest 2007, 131(2):335-336. 10.1378/chest.06-2736, 17296627.
6. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-968. 10.1183/09031936.05.00035205, 16264058.
7. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest 2007, 131(2):349-355. 10.1378/chest.06-1349, 17296632.
8. Torén K, Brisman J, Järvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 1993, 104(2):600-608. 10.1378/chest.104.2.600, 7802735.
9. Torén K, Palmqvist M, Löwhagen O, Balder B, Tunsäter A. Self-reported asthma was biased in relation to disease severity while reported year of asthma onset was accurate. J Clin Epidemiol 2006, 59(1):90-93. 10.1016/j.jclinepi.2005.03.019, 16360566.
10. Mintz ML, Yawn BP, Mannino DM, Donohue JF, Hanania NA, Grellet CA, Gilsenan AW, McLeod LD, Dalal AA, Raphiou IH, Prillaman BA, Crater GD, Cicale MJ, Mapel DW. Prevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc 2011, 86(5):375-381. 10.4065/mcp.2010.0787, 3084639, 21531880.
11. Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ, OPD Questionnaire Study Group Scoring system and clinical application of COPD diagnostic questionnaires. Chest 2006, 129(6):1531-1539. 10.1378/chest.129.6.1531, 16778271, OPD Questionnaire Study Group.
12. Barr RG, Herbstman J, Speizer FE, Camargo CA. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol 2002, 155(10):965-971. 10.1093/aje/155.10.965, 11994237.
13. Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B, Torén K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006, 130(5):1319-1325. 10.1378/chest.130.5.1319, 17099006.
14. Olin AC, Bake B, Torén K. Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest 2007, 131(6):1852-1856. 10.1378/chest.06-2928, 17565022.
15. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl 1993, 16:5-40.
16. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management and prevention of chronic pulmonary disease, 2011 [http://www.goldcopd.org/Guidelines/guidelines-resources.html], Global Initiative for Chronic Obstructive Lung Disease (GOLD).
17. Simple Interactive Statistical Analysis (SISA) free software,Southampton,UK 2013, Available at [http://www.quantitativeskills.com/sisa/statistics/diagnos.htm].
18. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007, 30(5):993-1013. 10.1183/09031936.00082507, 17978157.
19. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977, 105(5):488-495.
20. Kotz D, Nelemans P, Van Schayck CP, Wesseling GJ. External validation of a COPD diagnostic questionnaire. Eur Respir J 2008, 31(2):298-303. 10.1183/09031936.00074307, 17959636.
21. Mannino DM. Searching for COPD: are questionnaires the answer?. COPD 2010, 7(5):313-314. 10.3109/15412555.2010.512510, 20854044.
22. Lyngsø AM, Backer V, Gottlieb V, Nybo B, Ostergaard MS, Frølich A. Early detection of COPD in primary care-the Copenhagen COPD Screening Project. BMC Public Health 2010, 10:524. 10.1186/1471-2458-10-524, 2940916, 20809934.
23. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001, 119(6):1691-1695. 10.1378/chest.119.6.1691, 11399692.
24. Schneider A, Ay M, Faderl B, Linde K, Wagenpfeil S. Diagnostic accuracy of clinical symptoms in obstructive airway diseases varied within different health care sectors. J Clin Epidemiol 2012, 65(8):846-854. 10.1016/j.jclinepi.2011.12.014, 22640568.
25. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008, 63(5):402-407. 10.1136/thx.2007.085456, 18234906.
26. Soriano JB, Rodríguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc 2011, 8(4):363-367. 10.1513/pats.201102-017RM, 21816993.
27. Hagstad S, Ekerljung L, Lindberg A, Backman H, Rönmark E, Lundbäck B. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med 2012, 106(7):980-988. 10.1016/j.rmed.2012.03.010, 22498109.
28. Ulrik CS, Løkke A, Dahl R, Dollerup J, Hansen G, Cording PH, Andersen KK, TOP study group Early detection of COPD in general practice. Int J Chron Obstruct Pulmon Dis 2011, 6:123-127. 3048088, 21407825, TOP study group.
29. National Institute for Clinical Excellence (NICE) Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004, 59(Suppl 1):1-232. National Institute for Clinical Excellence (NICE).
30. Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, Small I, General Practice Airways Group Diagnostic spirometry in primary care: proposed standards for general practice compliant with American thoracic society and European respiratory society recommendations: a general practice airways group (GPIAG). Prim Care Respir J 2009, 18(3):130-147. 10.4104/pcrj.2009.00054, 19684995, General Practice Airways Group.
31. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003, 58(8):659-664. 10.1136/thorax.58.8.659, 1746778, 12885978.
32. Lehmann S, Bakke PS, Eide GE, Humerfelt S, Gulsvik A. Bronchodilator reversibility testing in an adult general population; The importance of smoking and anthropometrical variables on the response to a B2-agonist. Pulm Pharmacol Ther 2006, 19(4):272-280. 10.1016/j.pupt.2005.07.006, 16169762.
33. Meslier N, Racineux JL, Six P, Lockhart A. Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: a statistical approach. Eur Respir J 1989, 2(6):497-505.
34. Ibert P, Agusti A, Edwards L, TalSinger R, Yates J, Bakke P, Celli BR, Coxson HO, Crim C, Lomas DA, Macnee W, Miller B, Rennard S, Silverman EK, Vestbo J, Wouters E, Calverley P. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax 2012, 67(8)):701-708.
35. Schermer T, Heijdra Y, Zadel S, van den Bemt L, Boonman-de Winter L, Dekhuijzen R, Smeele I. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med 2007, 101(6):1355-1362. 10.1016/j.rmed.2006.09.024, 17098407.